Back
Phathom Pharmaceuticals Vs. BioNTech SE Industry Stock Comparison
Buy
62
PHAT
Phathom Pharmaceuticals
Last Price:
18.71
Seasonality Move:
-9.67%
Buy
52
BNTX
BioNTech SE
Last Price:
112.39
Seasonality Move:
12.7%
Buy
62
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $19.25. The Score for PHAT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
BioNTech SE (BNTX)
is a Buy
Is BioNTech SE a Buy, Sell or Hold?
- The current BioNTech SE [BNTX] share price is $115.62. The Score for BNTX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- BNTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $19.25
The current trend is moderately bullish and PHAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
BNTX Stock Price Chart
What is BioNTech SE's stock price today?
-
The BioNTech SE share price today is $115.62
The current trend is moderately bullish and BNTX is experiencing selling pressure, which indicates risk of future bearish movement.
PHAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.64 | Buy |
| Relative Strength Index (14 RSI): | 71.51 | Buy |
| Chaikin Money Flow: | 686596 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.56 - 18.4) | Buy |
| Bollinger Bands (100): | (9.43 - 14.73) | Buy |
BNTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.77 | Buy |
| Relative Strength Index (14 RSI): | 70.24 | Buy |
| Chaikin Money Flow: | -1842663 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (82.95 - 108.15) | Buy |
| Bollinger Bands (100): | (81.16 - 99.5) | Buy |
PHAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.58 | Buy |
| 20-day SMA: | 16.79 | Buy |
| 50-day SMA: | 13.77 | Buy |
| 200-day SMA: | 10.45 | Buy |
| 8-day EMA: | 18.47 | Buy |
| 20-day EMA: | 16.97 | Buy |
| 50-day EMA: | 14.61 | Buy |
| 200-day EMA: | 11.63 | Buy |
BNTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 111.6 | Buy |
| 20-day SMA: | 97.65 | Buy |
| 50-day SMA: | 89.56 | Buy |
| 200-day SMA: | 93.09 | Buy |
| 8-day EMA: | 112.27 | Buy |
| 20-day EMA: | 101.76 | Buy |
| 50-day EMA: | 93.73 | Buy |
| 200-day EMA: | 94.71 | Buy |
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.50 per share, an increase next quarter of $0.54 per share, a decrease this year of $1.71 per share, and an increase next year of $1.35 per share.
BioNTech SE Earnings Growth & BNTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.72 per share, an increase next quarter of $0.10 per share, a decrease this year of $7.38 per share, and a decrease next year of $0.37 per share.
Phathom Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioNTech SE Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||